Blog
RSS FeedPosted by Michael Wonder on 30 Apr 2020
Teva Canada announces the launch of Ajovy for the preventive treatment of migraine in adults who have at least four migraine days per month
29 April 2020 - Ajovy is the first and only anti-CGRP treatment with both quarterly and monthly dosing for the preventive ...
Posted by Michael Wonder on 29 Apr 2020
Health Canada approves Rozlytrek (entrectinib) for NTRK gene fusion-positive solid tumours in locally advanced or metastatic patients
28 April 2020 - Data show more than half of trial patients across all 10 tumour types studied had responses to ...
Posted by Michael Wonder on 21 Apr 2020
Alk announces Health Canada approval of Itulatek SLIT tablets for the treatment of tree pollen allergy
20 April 2020 - Over 20% of Canadians with allergies are impacted by tree pollen. ...
Posted by Michael Wonder on 19 Apr 2020
Knight Therapeutics announces approval of Ibrelsa in Canada
17 April 2020 - Knight Therapeutics announced that Health Canada has approved Ibrelsa (tenapanor) for the treatment of irritable ...
Posted by Michael Wonder on 17 Apr 2020
Health Canada approves an extended indication for Kisqali (ribociclib) in combination treatment
16 April 2020 - Breast cancer is the most common female cancer in Canada. ...
Posted by Michael Wonder on 08 Apr 2020
Advanced Accelerator Applications announces Health Canada approval of Netspot diagnostic imaging agent kit to detect neuroendocrine tumours
7 April 2020 - Netspot is the first and only kit for the preparation of gallium (68 Ga) oxodotreotide injection for ...
Posted by Michael Wonder on 21 Mar 2020
Janssen announces Health Canada approval of Cabenuva, the first long-acting regimen for the treatment of HIV
20 March 2020 - Cabenuva offers adults living with HIV a new once-monthly injectable option for maintaining viral suppression. ...
Posted by Michael Wonder on 10 Mar 2020
Health Canada approves fast-acting mealtime insulin, Fiasp, for children with diabetes
9 March 2020 - Health Canada also expands Fiasp approval to include insulin infusion pumps. ...
Posted by Michael Wonder on 04 Mar 2020
Novartis receives Health Canada approval for Mayzent (siponimod) to treat secondary progressive multiple sclerosis with active disease
3 March 2020 - Approval is based on the Phase III EXPAND trial, the largest controlled clinical study of people living ...
Posted by Michael Wonder on 03 Mar 2020
Cablivi (caplacizumab) approved by Health Canada for adults living with acquired thrombotic thrombocytopenic purpura
2 March 2020 - Cablivi is the first treatment approved in Canada for aTTP, a life-threatening blood clotting disorder. ...
Posted by Michael Wonder on 28 Feb 2020
Nuvo Pharmaceuticals announces Health Canada approves Suvexx for the acute treatment of migraine
27 February 2020 - Canadian launch anticipated in the second half of 2020. ...
Posted by Michael Wonder on 26 Feb 2020
Janssen receives Health Canada approval of Balversa (erdafitinib), the first FGFR kinase inhibitor for the treatment of patients with locally advanced or metastatic urothelial carcinoma with certain FGFR genetic alterations
24 February 2020 - Diagnostic testing is available to identify which patients are most likely to benefit from BALVERSA, offering a ...
Posted by Michael Wonder on 12 Feb 2020
Health Canada has approved Taltz (ixekizumab) for the treatment of active ankylosing spondylitis (radiographic axial spondyloarthritis)
11 February 2020 - Eli Lilly Canada announced today that Health Canada approved Taltz (ixekizumab) on 4 February 2020, for the ...
Posted by Michael Wonder on 29 Jan 2020
Health Canada approves new indication for Invokana (canagliflozin) to reduce the risks associated with diabetic kidney disease in patients with type 2 diabetes
28 January 2020 - INVOKANA® is the only diabetes treatment in Canada approved to treat this patient group ...
Posted by Michael Wonder on 28 Jan 2020
Jubilant Radiopharma Receives Approval from Health Canada for Drax Exametazime
27 January 2020 - Jubilant Radiopharma announced today that the company received approval from Health Canada for Drax Exametazine (Kit ...